Realizing the Promise of Pharmacogenomics - Georgetown University

Sustained responders exhibited 112 distinct genes and regulatory patterns linked to ketamine efficacy, with key biomarkers including DENN domain containing 5B ( ...







Molecular genetics of substance use disorders - DRUGZ
Tardive dyskinesia (TD) is a movement disorder that may develop in schizophrenia patients being treated long-term with antipsychotic medication.
Pharmacogenomic Study of SARS-CoV-2 Treatments
Based on present knowledge, in this work we review the importance of the pharmacogenetic tests in the treatment with antipsychotic drugs. Many associations have ...
Programmation en langage Java - LACL
Le cours ce compose d'une introduction à la matière et de trois chapitres comprenant chacun des exercices avec leurs corrigés. Le premier chapitre porte sur les ...



Autres Cours:

Investigation of the HSPG2 Gene in Tardive Dyskinesia - CORE